-
Innovation Ranking
NewInnovation Ranking – GlaxoSmithKline Plc
GSK plc (GSK) is a healthcare company that focuses on developing, manufacturing and commercializing general medicines, specialty medicines and vaccines. It offers drugs for the treatment of diseases such as HIV, respiratory, cancer, immuno-inflammation, anti-viral, central nervous system (CNS), metabolic, cardiovascular, and urogenital, anti-bacterials, dermatology and rare diseases. The company also offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and gastro-intestinal diseases. GSK’s vaccine portfolio covers various diseases including hepatitis, diphtheria, tetanus, whooping cough, rotavirus and...
-
Company Insights
GlaxoSmithKline Plc – Digital Transformation Strategies
GlaxoSmithKline digital transformation strategies report overview GlaxoSmithKline is harnessing the power of digital technologies such as AI, ML, and deep learning to accelerate the drug discovery and development process and reduce the time and operational costs. The annual ICT spending of GlaxoSmithKline was estimated at $892.7 million in 2023. A major share of this spending is earmarked for acquiring software, ICT services, and consulting from vendors. GlaxoSmithKline is a healthcare company that focuses on developing, manufacturing, and commercializing pharmaceuticals, vaccines,...
-
Product Insights
Glaxosmithkline Shewalton Road Solar PV Park
Glaxosmithkline Shewalton Road Solar PV Park is a solar PV project located in Scotland, United Kingdom. The project is owned and developed by The Farm Energy Co Ltd. The project is currently under construction. Empower your strategies with our Glaxosmithkline Shewalton Road Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends...
-
Product Insights
GlaxoSmithKline – GSK Tuas Vaccines Facility Expansion – South West
Equip yourself with the essential tools needed to make informed and profitable decisions with our GlaxoSmithKline – GSK Tuas Vaccines Facility Expansion – South West report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Acquire a thorough understanding of...
-
Sector Analysis
Ovarian Cancer Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032
Ovarian Cancer Market Report Overview The ovarian cancer market across the 7MM was valued at $3.3 billion in 2022. The market will grow at a CAGR of more than 1% from 2022 to 2032. The 7MM includes the US, France, Germany, Italy, Spain, the UK, and Japan. Ovarian cancer is one of the most lethal gynecological cancers worldwide. Approximately 90% of ovarian cancer cases are epithelial, with distinct sites of origin arising from the ovarian surface epithelium or distal fallopian...
-
Sector Analysis
Hot Drinks Market Opportunities, Trends, Growth Analysis and Forecast to 2027
Hot Drinks Market Report Overview The hot drinks market size was estimated at $104.6 billion in 2022 and is likely to grow at a CAGR of more than 6% from 2022 to 2027. A surge in home consumption, increasing purchasing power, and a shift toward healthier products are predicted to drive market growth in the coming years. Hot Drinks Market Outlook 2022-2027 ($ Billion) Buy the Full Report for Hot Drinks Market Forecasts Download a Free Sample Report The Hot...
-
Sector Analysis
Contract Pharmaceutical Dose Manufacturing Industry – Composition, Size, Market Share and Outlook, 2023 Edition
Contract Pharmaceutical Dose Manufacturing Industry Overview The total dose CMO contract revenue in 2022 represented significant growth over 2021 revenue. The growth rate was the highest recorded since 2011 for commercial contract dose manufacturing revenues, and surprisingly adds to the strong growth experienced in 2021, despite demand for COVID-19 vaccines and therapies waning in 2022. The Contract Pharmaceutical Dose Manufacturing Industry report is a comprehensive look at the finished dose contract manufacturing landscape in 2023. It includes an analysis of...
-
Sector Analysis
Vietnam OTC Healthcare Market Opportunities, Trends, Growth Analysis and Forecast to 2027
Vietnam OTC Healthcare Market Report Overview The Vietnamese OTC healthcare market size was estimated at VND37.7 trillion in 2022 and is likely to grow at a CAGR of more than 10% from 2022 to 2027. Vietnam OTC Healthcare Market Outlook 2022-2027 (VND Trillion) Buy the Full Report for Vietnam OTC Healthcare Market Forecasts Download a Free Sample Report The Vietnam OTC healthcare market research report includes country overview analysis, category and segment coverage, distribution channel insights, macroeconomic analysis, and competitive...
-
Track & Monitor
Clinical Trials Feasibility Risk Assessment and Planning for Success – A Depression Case Study
This report provides the global clinical trial landscape for depression and identifies key analysis of the main features in order to run similar trials successfully. As the prevalence of depression has increased, the outlook of it has also changed in positive ways. Better support and services for depression as well as the increase of discussing this order has lead to an increase of depression clinical trials. The COVID-19 pandemic has played a major role in that.
-
Sector Analysis
COVID-19 Vaccines Market Opportunity Assessment, Epidemiology, Disease Management, Clinical Trials, Unmet Needs and Forecast to 2026
COVID-19 Vaccines Market Report Overview The sales of COVID-19 vaccines across the 7MM reached $25 billion in 2021 and consisted of Tour authorized products: Comirnaty, Spikevax, Vaxzevria, and Jcovden. the COVID-19 vaccines market declined across the 7MM in 2022 as most individuals completed primary vaccinations and received at least one dose of an updated bivalent mRNA booster vaccine. Overall, the COVID-19 vaccines market is expected to significantly decline across the 7MM during the forecast period, at a negative compound annual...